A recent outbreak of tuberculosis in Nunavut, with a population infection rate 62 times the Canadian average, points to a need to rebuild trust in public health to combat the disease, states an editorial published in CMAJ ...
Feb 14, 2011
4 / 5 (1)
0
(AP) -- Germany says it will halt all payments to a $21.7 billion global health fund until it gets answers about serious corruption allegations raised in articles by The Associated Press.
Jan 26, 2011
5 / 5 (1)
1
Identifying tuberculosis patients in Africa using passive methods is leaving many cases undiagnosed, according to researchers from the Netherlands, Kenya and the United States, who studied case detection methods in HIV-prone ...
Jan 14, 2011
not rated yet
0
A new study found that there is a serious increased risk of side effects requiring hospitalization in people over the age of 65 who are going through latent tuberculosis infection therapy, according to a study published in ...
Jan 10, 2011
not rated yet
0
The risk of tuberculosis (TB) and latent TB (in which the bacteria that cause TB lie dormant but can reactivate later to cause active TB disease) is higher in the prison population than in the general population. And importantly, ...
Dec 21, 2010
not rated yet
0
New research being presented at the 2010 International Pharmaceutical Federation (FIP) Pharmaceutical Sciences World Congress (PSWC) in association with the American Association of Pharmaceutical Scientists (AAPS) Annual ...
Nov 16, 2010
5 / 5 (1)
1
A rapid, low cost test for diagnosing tuberculosis (TB) – including multi-drug resistance – has been endorsed by the World Health Organisation (WHO) for use in resource-poor settings.
Nov 12, 2010
not rated yet
0
At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be ...
Sep 23, 2010
5 / 5 (1)
0
Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell ...
Sep 22, 2010
not rated yet
0
